Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Anna Truini, Simona Coco, Ernest Nadal, Carlo Genova, Marco Mora, Maria Giovanna Dal Bello, Irene Vanni, Angela Alama, Erika Rijavec, Federica Biello, Giulia Barletta, Domenico Franco Merlo, Alessandro Valentino, Paola Ferro, Gian Luigi Ravetti, Sara Stigliani, Antonella Vigani, Franco Fedeli, David G Beer, Silvio Roncella & 1 others Francesco Grossi

Research output: Contribution to journalArticle

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal overall survival (OS) and to date no molecular markers are available to guide patient management. This study aimed to identify a prognostic miRNA signature in MPM patients who did not undergo tumor resection. Whole miRNA profiling using a microarray platform was performed using biopsies on 27 unresected MPM patients with distinct clinical outcome: 15 patients had short survival (OS36 months). Three prognostic miRNAs (mir-99a, let-7c, and miR-125b) encoded at the same cluster (21q21) were selected for further validation and tested on publicly available miRNA sequencing data from 72 MPM patients with survival data. A risk model was built based on these 3 miRNAs that was validated by quantitative PCR in an independent set of 30 MPM patients. High-risk patients had shorter median OS (7.6 months) as compared with low-risk patients (median not reached). In the multivariate Cox model, a high-risk score was independently associated with shorter OS (HR=3.14; 95% CI, 1.18-8.34; P=0.022). Our study identified that the downregulation of the miR-99a/let-7/miR-125b miRNA cluster predicts poor outcome in unresected MPM.
Original languageEnglish
Pages (from-to)68627-68640
Number of pages14
JournalOncotarget
Volume8
Issue number40
Publication statusPublished - Sep 15 2017

Fingerprint

MicroRNAs
Down-Regulation
Survival
Malignant Mesothelioma
Proportional Hazards Models
Neoplasms
Biopsy
Polymerase Chain Reaction

Keywords

  • Journal Article

Cite this

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma. / Truini, Anna; Coco, Simona; Nadal, Ernest; Genova, Carlo; Mora, Marco; Dal Bello, Maria Giovanna; Vanni, Irene; Alama, Angela; Rijavec, Erika; Biello, Federica; Barletta, Giulia; Merlo, Domenico Franco; Valentino, Alessandro; Ferro, Paola; Ravetti, Gian Luigi; Stigliani, Sara; Vigani, Antonella; Fedeli, Franco; Beer, David G; Roncella, Silvio; Grossi, Francesco.

In: Oncotarget, Vol. 8, No. 40, 15.09.2017, p. 68627-68640.

Research output: Contribution to journalArticle

Truini, A, Coco, S, Nadal, E, Genova, C, Mora, M, Dal Bello, MG, Vanni, I, Alama, A, Rijavec, E, Biello, F, Barletta, G, Merlo, DF, Valentino, A, Ferro, P, Ravetti, GL, Stigliani, S, Vigani, A, Fedeli, F, Beer, DG, Roncella, S & Grossi, F 2017, 'Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma', Oncotarget, vol. 8, no. 40, pp. 68627-68640.
Truini, Anna ; Coco, Simona ; Nadal, Ernest ; Genova, Carlo ; Mora, Marco ; Dal Bello, Maria Giovanna ; Vanni, Irene ; Alama, Angela ; Rijavec, Erika ; Biello, Federica ; Barletta, Giulia ; Merlo, Domenico Franco ; Valentino, Alessandro ; Ferro, Paola ; Ravetti, Gian Luigi ; Stigliani, Sara ; Vigani, Antonella ; Fedeli, Franco ; Beer, David G ; Roncella, Silvio ; Grossi, Francesco. / Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma. In: Oncotarget. 2017 ; Vol. 8, No. 40. pp. 68627-68640.
@article{8167b72ef72647868455f553da943386,
title = "Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma",
abstract = "Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal overall survival (OS) and to date no molecular markers are available to guide patient management. This study aimed to identify a prognostic miRNA signature in MPM patients who did not undergo tumor resection. Whole miRNA profiling using a microarray platform was performed using biopsies on 27 unresected MPM patients with distinct clinical outcome: 15 patients had short survival (OS36 months). Three prognostic miRNAs (mir-99a, let-7c, and miR-125b) encoded at the same cluster (21q21) were selected for further validation and tested on publicly available miRNA sequencing data from 72 MPM patients with survival data. A risk model was built based on these 3 miRNAs that was validated by quantitative PCR in an independent set of 30 MPM patients. High-risk patients had shorter median OS (7.6 months) as compared with low-risk patients (median not reached). In the multivariate Cox model, a high-risk score was independently associated with shorter OS (HR=3.14; 95{\%} CI, 1.18-8.34; P=0.022). Our study identified that the downregulation of the miR-99a/let-7/miR-125b miRNA cluster predicts poor outcome in unresected MPM.",
keywords = "Journal Article",
author = "Anna Truini and Simona Coco and Ernest Nadal and Carlo Genova and Marco Mora and {Dal Bello}, {Maria Giovanna} and Irene Vanni and Angela Alama and Erika Rijavec and Federica Biello and Giulia Barletta and Merlo, {Domenico Franco} and Alessandro Valentino and Paola Ferro and Ravetti, {Gian Luigi} and Sara Stigliani and Antonella Vigani and Franco Fedeli and Beer, {David G} and Silvio Roncella and Francesco Grossi",
year = "2017",
month = "9",
day = "15",
language = "English",
volume = "8",
pages = "68627--68640",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "40",

}

TY - JOUR

T1 - Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

AU - Truini, Anna

AU - Coco, Simona

AU - Nadal, Ernest

AU - Genova, Carlo

AU - Mora, Marco

AU - Dal Bello, Maria Giovanna

AU - Vanni, Irene

AU - Alama, Angela

AU - Rijavec, Erika

AU - Biello, Federica

AU - Barletta, Giulia

AU - Merlo, Domenico Franco

AU - Valentino, Alessandro

AU - Ferro, Paola

AU - Ravetti, Gian Luigi

AU - Stigliani, Sara

AU - Vigani, Antonella

AU - Fedeli, Franco

AU - Beer, David G

AU - Roncella, Silvio

AU - Grossi, Francesco

PY - 2017/9/15

Y1 - 2017/9/15

N2 - Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal overall survival (OS) and to date no molecular markers are available to guide patient management. This study aimed to identify a prognostic miRNA signature in MPM patients who did not undergo tumor resection. Whole miRNA profiling using a microarray platform was performed using biopsies on 27 unresected MPM patients with distinct clinical outcome: 15 patients had short survival (OS36 months). Three prognostic miRNAs (mir-99a, let-7c, and miR-125b) encoded at the same cluster (21q21) were selected for further validation and tested on publicly available miRNA sequencing data from 72 MPM patients with survival data. A risk model was built based on these 3 miRNAs that was validated by quantitative PCR in an independent set of 30 MPM patients. High-risk patients had shorter median OS (7.6 months) as compared with low-risk patients (median not reached). In the multivariate Cox model, a high-risk score was independently associated with shorter OS (HR=3.14; 95% CI, 1.18-8.34; P=0.022). Our study identified that the downregulation of the miR-99a/let-7/miR-125b miRNA cluster predicts poor outcome in unresected MPM.

AB - Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal overall survival (OS) and to date no molecular markers are available to guide patient management. This study aimed to identify a prognostic miRNA signature in MPM patients who did not undergo tumor resection. Whole miRNA profiling using a microarray platform was performed using biopsies on 27 unresected MPM patients with distinct clinical outcome: 15 patients had short survival (OS36 months). Three prognostic miRNAs (mir-99a, let-7c, and miR-125b) encoded at the same cluster (21q21) were selected for further validation and tested on publicly available miRNA sequencing data from 72 MPM patients with survival data. A risk model was built based on these 3 miRNAs that was validated by quantitative PCR in an independent set of 30 MPM patients. High-risk patients had shorter median OS (7.6 months) as compared with low-risk patients (median not reached). In the multivariate Cox model, a high-risk score was independently associated with shorter OS (HR=3.14; 95% CI, 1.18-8.34; P=0.022). Our study identified that the downregulation of the miR-99a/let-7/miR-125b miRNA cluster predicts poor outcome in unresected MPM.

KW - Journal Article

M3 - Article

VL - 8

SP - 68627

EP - 68640

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 40

ER -